| Literature DB >> 35808693 |
Ying Huo1, Yingying Liu1, Mingfeng Xia1, Hong Du1, Zhaoyun Lin2, Bin Li3, Hongbin Liu1.
Abstract
Nanocellulose has lately emerged as one of the most promising "green" materials due to its unique properties. Nanocellulose can be mainly divided into three types, i.e., cellulose nanocrystals (CNCs), cellulose nanofibrils (CNFs), and bacterial cellulose (BC). With the rapid development of technology, nanocellulose has been designed into multidimensional structures, including 1D (nanofibers, microparticles), 2D (films), and 3D (hydrogels, aerogels) materials. Due to its adaptable surface chemistry, high surface area, biocompatibility, and biodegradability, nanocellulose-based composite materials can be further transformed as drug delivery carriers. Herein, nanocellulose-based composite material used for drug delivery was reviewed. The typical drug release behaviors and the drug release mechanisms of nanocellulose-based composite materials were further summarized, and the potential application of nanocellulose-based composite materials was prospected as well.Entities:
Keywords: aerogel; drug delivery; film; hydrogel; microparticles; nanocellulose
Year: 2022 PMID: 35808693 PMCID: PMC9268916 DOI: 10.3390/polym14132648
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.967
Figure 1Schematic illustration of different nanocellulose-based materials used for drug delivery.
Comparison of structure parameters of different types of nanocellulose.
| Types of | Structure Properties | Mechanical Properties | |||
|---|---|---|---|---|---|
| Diameter (nm) | Length (nm) | Crystallinity | Young’s | Tensile Strength (GPa) | |
| CNCs | 3–50 | 100–500 | ~90 | 50–140 | 8–10 |
| CNFs | 3–60 | ≥103 | 50–90 | 50–160 | 0.8–1 |
| BC | 20–100 | ≥103 | 84–89 | 78 | 0.2–2 |
Figure 2(a) Schematic illustration of nanocomposite filament; (b) Photography and optical microscopy images of hydroentangled CNCs-based INC filament; (c) Cumulative release profiles of DOX-loaded CNCs-based INC filaments in different pH values at 37 °C. The inset shows the cumulative drug release in the first 1 h [76].
Figure 3(a) Schematic illustration of the preparation of the nanocrystalline/chitosan; (b) Release profile of doxorubicin hydrochloride from the composite film at 37 °C using PBS buffer as release media [83].
Figure 4(a) Schematic illustration of the fabrication of the MPDA@GO/CNFs composite hydrogel; (b) NIR-light-triggered drug release behavior from MPDA@GO/CNFs composite hydrogel in different PBS solution at 37 °C; (c) In vitro drug release profiles of the MPDA@GO/CNFs composite hydrogel [106].
Figure 5(a) Schematic illustration of the preparation of the injectable CNCs hydrogels; (b) In vitro drug release from CNCs hydrogels [111].
Figure 6(a) Schematic illustration of the preparation of the PEI-BC composite aerogels; (b) The cumulative release curves of aspirin [128].
Nanocellulose-based materials used in hydrophilic-drug delivery applications.
| Dimensions | Drug Delivery Carriers | Hydrophilic-Drug | Drug Release Behaviors | Drug Release | References |
|---|---|---|---|---|---|
| 1D | Poly(lactic acid)/CNCs nanocomposite fibers | Columbia blue | Little burst release (<5%) in the first 4 h. | Fickian diffusion | [ |
| CNCs-hordein/ | Riboflavin | After 24 h, the cumulative release amount was 26.99%. | - | [ | |
| CNFs/poly(N-isopropylacrylamide) hybrid microspheres | 5-Fluorouracil | The cumulative drug released amount was 89% within 1 h at 22 °C. | Fickian diffusion | [ | |
| CNCs/chitosan | Procaine | In the first 10 min, drug release rate was relatively fast; then, it became slower in the next 1 h. | - | [ | |
| 2D | Nanocellulose/ | Hydroxychloroquine | In the first 2 h, the drug release amount from the pectin films | Fick’s diffusion | [ |
| Chitosan/CNCs films | Doxorubicin | Under acidic pH | Fickian diffusion | [ | |
| CNFs/polyvinyl | Acetaminophen | - | Diffusion | [ | |
| BC composite | Tetracycline | The drug release amount was 90% within 10 h in HEPES buffers. | - | [ | |
| 3D | Polyacrylamide/ | Niacinamide | The cumulative drug release amount was 45% with 350 min. | Pseudo-Fickian | [ |
| CNFs/polydopamine | Tetracycline | In acid PBS solution, 70% of the loaded drugs were released | Anomalous transport | [ | |
| CNFs/polyethylenimine aerogels | Sodium salicylate | In SIF condition with a pH of 7.4, the | Pseudo-second-order | [ | |
| CNFs aerogel | Bendamustine | The cumulative drug release amount was 78% ± 2.28% in 24 h. | Non-Fickian mechanism | [ | |
| CNFs/ | Doxorubicin | The cumulative drug release amount was 59.45% at pH of 3 and 37 °C. | - | [ | |
| CNFs/hydroxypropylmethylcellulose | Ketorolac | The cumulative drug release amount was 95.12% after 8 h under PBS conditions of 7.4. | Non-Fickian diffusion | [ | |
| Mesoporous | Tetracycline | In the first 1 h, burst | Anomalous transport | [ |
Figure 7(a) Schematic illustration of the preparation of the 5-fluorouracil-loaded CNF/gelation hydrogels; (b) Drug release profiles of different hydrogels; (c) Drug release profiles of the hydrogel at different pH environments [154].
Nanocellulose-based materials used in hydrophobic-drug delivery applications.
| Dimensions | Drug Delivery Carriers | Hydrophobic-Drug Models | Drug Release Behaviors | Drug Release | References |
|---|---|---|---|---|---|
| 1D | CNCs–cetyltrimethylammonium | Paclitaxel, | A total of 75% of the drug was released over 4 days. | - | [ |
| CNCs/rarasaponin | Tetracycline | More drugs released from neutral | Pseudo-first-order | [ | |
| 2D | BC/hyaluronic acid/ | Diclofenac | The maximum | Non-Fickian | [ |
| CNFs/poly(glycerol | Curcumin | The cumulative drug-released amount was less than 2% with five months in PBS under pH of 7.4. | - | [ | |
| BC/polyvinyl alcohol films | Vanillin | The diffusion process reached | Fickian | [ | |
| 3D | BC/sodium alginate hybrid hydrogels | Ibuprofen | During the first 2 h, the drug release amount was less than 10% in acidic | Non-Fickian | [ |
| Polyethylenimine/BC aerogels | Aspirin | The cumulative drug release was 80.6% with 25 h in pH condition of 7.5. | - | [ | |
| Zeolitic imidazolate framework-8@PCNFs composite hydrogel | Curcumin | Under pH condition of 2.5, the maximum | Anomalous | [ |
Figure 8Schematic illustration of curcumin-loaded membrane and the drug release curve of curcumin [167].
Exponent n and the drug release mechanism from the controlled-drug-delivery carriers of different geometry [148].
| Exponent, | Drug Release Mechanisms | ||
|---|---|---|---|
| Thin Films | Cylinders | Spheres | |
| 0.5 | 0.45 | 0.43 | Fickian diffusion |
| 0.5 < | 0.45 < | 0.43 < | Anomalous transport |
| 1 | 0.89 | 0.85 | Case-II transport |